Viswa Colluru
Founder and CEO
AI-powered drug discovery from nature’s chemistry
Enveda (also known as Enveda Biosciences) is a Boulder-based biotech that uses AI and mass spectrometry to mine plants and microbes for new medicines. Its PRISM platform interprets chemical data at scale to advance clinical candidates. In September 2026 the company announced a Series E financing to advance programs including ENV-294 and ENV-308 and to continue scaling PRISM. Founded in 2019 by CEO Viswa Colluru. Website: https://enveda.com.
Founder and CEO